Molecular Characterization, Drug Resistance and Virulence Analysis of Constitutive and Inducible Clindamycin Resistance Staphylococcus aureus Strains Recovered from Clinical Samples, Tehran – Iran

References

• Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661. doi:10.1128/CMR.00134-1426016486
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2012;2:12. doi:10.3389/fcimb.2012.0001222919604
   PubMed Web of Science ®Google Scholar
• Adhikari R, Shrestha S, Barakoti A, Amatya R. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. BMC Infect Dis. 2017;17(1):483. doi:10.1186/s12879-017-2584-528693489
   PubMed Web of Science ®Google Scholar
• Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn J Infect Dis. 2005;58:104–106.15858290
   PubMed Web of Science ®Google Scholar
• Khashei R, Malekzadegan Y, Ebrahim-Saraie HS, Razavi Z. Phenotypic and genotypic characterization of macrolide, lincosamide and streptogramin B resistance among clinical isolates of staphylococci in southwest of Iran. BMC Res Notes. 2018;11(1):1–6. doi:10.1186/s13104-018-3817-429291749
   PubMedGoogle Scholar
• Sasirekha B, Usha M, Amruta J, Ankit S, Brinda N, Divya R. Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus. 3 Biotech. 2014;4(1):85–89. doi:10.1007/s13205-013-0133-5
   Google Scholar
• Abbasi-Montazeri E, Khosravi AD, Feizabadi MM, et al. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin resistance from patients and personnel in a burn center. Burns. 2013;39(4):650–654. doi:10.1016/j.burns.2013.02.00523499497
   PubMed Web of Science ®Google Scholar
• Gadepalli R, Dhawan B, Mohanty S, et al. Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Diagn Microbiol Infect Dis. 2007;58(1):125–127. doi:10.1016/j.diagmicrobio.2006.10.01217240103
   PubMed Web of Science ®Google Scholar
• Yousefi M, Fallah F, Arshadi M, Pourmand M, Hashemi A, Pourmand G. Identification of tigecycline-and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran. New Microbes New Infect. 2017;19:8–12. doi:10.1016/j.nmni.2017.05.00928663797
   PubMedGoogle Scholar
• Moosavian M, Shoja S, Rostami S, Torabipour M, Farshadzadeh Z. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus due to erm genes, Iran. Iran J Microbiol. 2014;6(5):421.25926961
   PubMedGoogle Scholar
• Lewis JS, Jorgensen JH. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005;40(2):280–285. doi:10.1086/42689415655748
   PubMed Web of Science ®Google Scholar
• Nezhad RR, Meybodi SM, Rezaee R, Goudarzi M, Fazeli M. Molecular characterization and resistance profile of methicillin resistant Staphylococcus aureus strains isolated from hospitalized patients in intensive care unit, Tehran-Iran. Jundishapur J Microbiol. 2017;10.
   Web of Science ®Google Scholar
• Castanheira M, Watters AA, Bell JM, Turnidge JD, Jones RN. Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008. Antimicrob Agents Chemother. 2010;54:3614–3617. doi:10.1128/AAC.01390-0920566766
   PubMed Web of Science ®Google Scholar
• Hirose M, Kobayashi N, Ghosh S, et al. Identification of Staphylocoagulase genotypes I-X and discrimination of Type IV and V subtypes by multiplex PCR assay for clinical isolates of Staphylococcus aureus. Jpn J InfectDis. 2010;63:257–263.
   Web of Science ®Google Scholar
• Kilany AA. Inducible clindamycin resistance among clinical isolates of Staphylococcus aureus. Menoufia Med J. 2016;29:228. doi:10.4103/1110-2098.192418
   Google Scholar
• Lall M, Sahni A. Prevalence of inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Med J Armed Forces India. 2014;70:43–47. doi:10.1016/j.mjafi.2013.01.00424623947
   PubMedGoogle Scholar
• Sedaghat H, Esfahani BN, Mobasherizadeh S, et al. Phenotypic and genotypic characterization of macrolide resistance among Staphylococcus aureus isolates in Isfahan, Iran. Iran J Microbiol. 2017;9:264.29296270
   PubMedGoogle Scholar
• Eksi F, Gayyurhan ED, Bayram A, Karsligil T. Determination of antimicrobial susceptibility patterns and inducible clindamycin resistance in Staphylococcus aureus strains recovered from southeastern Turkey. J Microbiol Immunol Infect. 2011;44(1):57–62. doi:10.1016/j.jmii.2011.01.01121531354
   PubMedGoogle Scholar
• Mansouri S, Sadeghi J. Inducible clindamycin resistance in methicillin-resistant and-susceptible Staphylococcus aureus isolated from south east of Iran. Jundishapur J Microbiol. 2014;7.
   Web of Science ®Google Scholar
• Aqel A, Ibrahim A, Shehabi A. Rare occurrence of mupirocin resistance among clinical Staphylococcus in Jordan. Acta Microbiol Imm H. 2012;59(2):239–247. doi:10.1556/AMicr.59.2012.2.8
   Web of Science ®Google Scholar
• Liu Q-Z, Wu Q, Zhang Y-B, et al. Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China. Int J Antimicrob Agents. 2010;35:114–118. doi:10.1016/j.ijantimicag.2009.09.01819939636
   PubMed Web of Science ®Google Scholar
• Shahsavan S, Emaneini M, Khoshgnab BN, et al. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients. Burns. 2012;38:378–382. doi:10.1016/j.burns.2011.09.00422040930
   PubMed Web of Science ®Google Scholar
• Barakat GI, Nabil YM. Correlation of mupirocin resistance with biofilm production in methicillin-resistant Staphylococcus aureus from surgical site infections in a tertiary centre, Egypt. J Glob Antimicrob Resist. 2016;4:16–20. doi:10.1016/j.jgar.2015.11.01027436387
   PubMed Web of Science ®Google Scholar
• González-Domínguez M, Seral C, Potel C, et al. Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) clones with high-level mupirocin resistance. Diagn Microbiol Infect Dis. 2016;85(2):213–217. doi:10.1016/j.diagmicrobio.2016.02.02127133306
   PubMed Web of Science ®Google Scholar
• Zorgani A, Elahmer O, Ziglam H, Ghenghesh KS. In-vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus isolated from wounds of burn patients in Tripoli-Libya. J Microbiol Infect D. 2012;2(3):109–112. doi:10.5799/ahinjs.02.2012.03.0053
   Google Scholar
• Oksuz L, Gurler N. Susceptibility of clinical methicillin-resistant Staphylococci isolates to new antibiotics. J Infect Dev Ctries. 2013;7(11):825–831. doi:10.3855/jidc.386724240040
   PubMed Web of Science ®Google Scholar
• Wang J-L, Tang H-J, Hsieh P-H, et al. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2012;40:103–107. doi:10.1016/j.ijantimicag.2012.03.01022612900
   PubMed Web of Science ®Google Scholar
• Rahimi F, Bouzari M, Katouli M, Pourshafie MR. Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. Jundishapur J Microbiol. 2013;6(2):144–149. doi:10.5812/jjm.4896
   Web of Science ®Google Scholar
• Deotale V, Mendiratta D, Raut U, Narang P. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Indian J Med. Microbiol. 2010;28(2):124. doi:10.4103/0255-0857.6248820404457
   PubMed Web of Science ®Google Scholar
• Yu F, Liu Y, Lu C, et al. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates. BMC Microbiol. 2015;15:210. doi:10.1186/s12866-015-0552-z26463589
   PubMed Web of Science ®Google Scholar
• Ardic N, Sareyyupoglu B, Ozyurt M, Haznedaroglu T, Ilga U. Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci. Microbiol Res. 2006;161(1):49–54. doi:10.1016/j.micres.2005.05.00216338590
   PubMed Web of Science ®Google Scholar
• Perumal N, Murugesan S, Krishnan P. Distribution of genes encoding aminoglycoside-modifying enzymes among clinical isolates of methicillin-resistant staphylococci. Indian J Med Microbiol. 2016;34(3):350. doi:10.4103/0255-0857.18833927514959
   PubMed Web of Science ®Google Scholar
• Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol. 2001;39(9):3115–3121. doi:10.1128/JCM.39.9.3115-3121.200111526138
   PubMed Web of Science ®Google Scholar
• Akpaka PE, Roberts R, Monecke S. Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago. J Infect Public Health. 2017;10(3):316–323. doi:10.1016/j.jiph.2016.05.01027328777
   PubMed Web of Science ®Google Scholar
• Fasihi Y, Saffari F, Ghahraman MRK, Kalantar-Neyestanaki D. Molecular detection of macrolide and lincosamide-resistance genes in clinical methicillin-resistant Staphylococcus aureus isolates from Kerman, Iran. Arch Pediatr Infect Dis. 2017;5.
   Google Scholar
• Schmitz F-J, Sadurski R, Kray A, et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother. 2000;45(6):891–894. doi:10.1093/jac/45.6.89110837446
   PubMed Web of Science ®Google Scholar
• Chavez-Bueno S, Bozdogan B, Katz K, et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005;49(6):2283–2288. doi:10.1128/AAC.49.6.2283-2288.200515917522
   PubMed Web of Science ®Google Scholar
• Afrough P, Pourmand MR, Sarajian AA, Saki M, Saremy S. Molecular investigation of Staphylococcus aureus, coa and spa genes in Ahvaz hospitals, staff nose compared with patients clinical samples. Jundishapur J Microbiol. 2013;6:1O.
   Web of Science ®Google Scholar
• Janwithayanuchit I, Ngam-Ululert S, Paungmoung P, Rangsipanuratn W. Epidemiologic study of methicillin-resistant Staphylococcus aureus by coagulase gene polymorphism. Sci Asia. 2006;32:127–132. doi:10.2306/scienceasia1513-1874.2006.32.127
   Google Scholar
• Omar NY, Ali HAS, Harfoush RAH, El Khayat EH. Molecular typing of methicillin resistant Staphylococcus aureus clinical isolates on the basis of protein A and coagulase gene polymorphisms. Int J Microbiol. 2014;2014.
   Google Scholar